Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-06 · accession 0001873919-24-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-08 | 2024-11-06+ | CADL | Aguilar Laura K. | 10% | D - Sale to Iss | $5.15 | -22.5K | 881.0K | -2% | -$115.8K |
| MI | 2024-11-08 | 2024-11-06+ | CADL | Aguilar Laura K. | 10% | D - Sale to Iss | $5.15 | -22.5K | 846.4K | -3% | -$115.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | CADL | 2024-11-06 | D | D | 7,500 | $5.33 | 888,512 | D By LKA 2022 Revocable Trust | — | — | (F1) Shares of common stock held by spouse LKA 2022 Revocable trust |
| 2 | Common | CADL | 2024-11-08 | D | D | 7,500 | $4.92 | 831,443 | I | — | — | |
| 3 | Common | CADL | 2024-11-08 | D | D | 7,500 | $4.92 | 873,512 | D | — | — | |
| 4 | Common | CADL | 2024-11-07 | D | D | 7,500 | $5.19 | 838,943 | I | — | — | |
| 5 | Common | CADL | 2024-11-07 | D | D | 7,500 | $5.19 | 881,012 | D By LKA 2022 Revocable Trust | — | — | (F1) Shares of common stock held by spouse LKA 2022 Revocable trust |
| 6 | Common | CADL | 2024-11-06 | D | D | 7,500 | $5.33 | 846,443 | I By LKA 2022 Revocable Trust | — | — | (F1) Shares of common stock held by spouse LKA 2022 Revocable trust |